INSM Share Price

Open 12.98 Change Price %
High 13.25 1 Day 0.15 1.16
Low 12.58 1 Week -0.55 -4.03
Close 13.10 1 Month 1.33 11.30
Volume 229388 1 Year -3.25 -19.88
52 Week High 19.30
52 Week Low 9.02
INSM Important Levels
Resistance 2 13.72
Resistance 1 13.47
Pivot 12.98
Support 1 12.73
Support 2 12.48
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
WRES 0.09 0.00%
SIRI 4.41 1.85%
QQQ 116.87 0.23%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ECTE 0.14 40.00%
BNSO 3.57 31.25%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
CRDS 5.45 25.87%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
IMRS 0.02 -33.33%
More..

Insmed, Inc. (NASDAQ: INSM)

INSM Technical Analysis 1.5
As on 6th Dec 2016 INSM Share Price closed @ 13.10 and we RECOMMEND Buy for LONG-TERM with Stoploss of 12.69 & Sell for SHORT-TERM with Stoploss of 13.95 we also expect STOCK to react on Following IMPORTANT LEVELS.
INSM Target for December
1st Target up-side 16.53
2nd Target up-side 18.54
3rd Target up-side 20.56
1st Target down-side 10.77
2nd Target down-side 8.76
3rd Target down-side 6.74
INSM Other Details
Segment EQ
Market Capital 202974992.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.insmed.com
INSM Address
INSM
9 Deer Park Drive
Suite C
Monmouth Junction, NJ 08852
United States
Phone: 732-997-4600
INSM Latest News
Investors are Keeping Tabs on Insmed Incorporated (NASDAQ:INSM)   The Business Journal   - 06th Dec 16
Option Market: Insmed Incorporated Risk Hits An Elevated Level   CML News   - 06th Dec 16
Breaking: Could Insmed Incorporated Gain Strenght? The Stock Reaches 1 Year Low   Frisco Fastball   - 01st Dec 16
Stock Mover of the Day: What's in Insmed Incorporated After Today's ...   Frisco Fastball   - 26th Nov 16
Insmed Incorporated (NASDAQ:INSM) To Report June 2016 Results   The Voice Registrar   - 24th Nov 16
Company Update (NASDAQ:INSM): Insmed Incorporated Reports 3Q:16 Financial ...   Smarter Analyst   - 03rd Nov 16
Company Update (NASDAQ:INSM): Insmed Incorporated Appoints Roger Adsett as ...   Smarter Analyst   - 27th Sep 16
Why Insmed Incorporated Shares Skyrocketed   Motley Fool   - 18th Jun 14
News Insmed Inc.INSM   Wall Street Journal   - 14th Feb 11
Virtual Stock Exchange   MarketWatch   - 22nd Dec 09
Interactive Technical Analysis Chart Insmed, Inc. ( INSM NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Insmed, Inc.
INSM Business Profile
Insmed Incorporated is a biopharmaceutical company focused on patients suffering with lung diseases through the development and commercialization of targeted inhalation therapies. The Company�s lead candidate ARIKACE, is engineered to deliver anti-infective directly to the site of lung infections for at least two identified patient populations: cystic fibrosis (CF) patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections (NTM). During the year ended December 31, 2011, the Company was focused on its ARIKACE clinical development program, which includes a phase II clinical study of ARIKACE in patients with NTM lung disease (TARGET-NTM), as well as a European and Canadian registration phase III clinical study of ARIKACE in CF patients with Pseudomonas lung infections (CLEAR-108). ARIKACE is considered a New Chemical Entity by the United States Food and Drug Administration (FDA), primarily due to its liposomal technology.